Studies examine cost-effectiveness of maternal RSV vaccination and nirsevimab in infants

Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness, according to two studies published online Nov. 25 in Pediatrics…